ORLANDO — The Democratic Party endorsed a "reasoned pathway to future legalization" of marijuana and called for the drug to be downgraded in the Controlled Substances Act, in a tense and unexpected victory for supporters of Sen. Bernie Sanders.
WeedLife News Network
ORLANDO — The Democratic Party endorsed a "reasoned pathway to future legalization" of marijuana and called for the drug to be downgraded in the Controlled Substances Act, in a tense and unexpected victory for supporters of Sen. Bernie Sanders.
Bruce Kennedy ~ WeedWorthy.com ~
A group of U.S. lawmakers is calling on the U.S. Drug Enforcement Administration (DEA) of remove federal barriers on medical marijuana research and to ease new medical research on cannabis and its derivatives.
Sen. Elizabeth Warren has signed on to a letter asking the U.S. Department of Justice and the Drug Enforcement Administration for an update on the agencies' decision about whether they plan to change marijuana's classification at the federal level. Marijuana is currently classified as a "Schedule I" drug under the Controlled Substances Act.
Rescheduling will not shut down the thousands of existing medical (or for that matter recreational) grows, processing facilities and dispensaries that serve people in about half of the U.S.
Rescheduling will not shut down the thousands of existing medical (or for that matter recreational) grows, processing facilities and dispensaries that serve people in about half of the U.S.
As the government considers reclassifying cannabis, researchers say easing the rules could lead to big advances.
President Barack Obama may smell something familiar on April 2 when marijuana activists inspired by comedian Bill Maher host what they believe will be a massive act of civil disobedience in front of the White House.
President Barack Obama may smell something familiar on April 2 when marijuana activists inspired by comedian Bill Maher host what they believe will be a massive act of civil disobedience in front of the White House.
INDIANAPOLIS -- Marijuana’s high-less cousin is a step closer to returning to Indiana. Lawmakers have allowed the state seed commissioner to license farmers to grow industrial hemp - if and when the federal government stops treating it like a Schedule I drug.
INDIANAPOLIS -- Marijuana’s high-less cousin is a step closer to returning to Indiana. Lawmakers have allowed the state seed commissioner to license farmers to grow industrial hemp - if and when the federal government stops treating it like a Schedule I drug.
BILLINGS - The battleground for medical marijuana in Montana is back, with both sides fired up, making their case to voters as signatures for initiatives are due in June.
MONTGOMERY, Ala. – For the last few years, the Alabama legislature has talked a lot about CBD oil. It’s derived from marijuana, but it can’t get you high. It can, however, make a big difference for patients who sometimes suffer multiple seizures a day.
MONTGOMERY, Ala. – For the last few years, the Alabama legislature has talked a lot about CBD oil. It’s derived from marijuana, but it can’t get you high. It can, however, make a big difference for patients who sometimes suffer multiple seizures a day.
Marijuana advocates hoping for a substantial shift in federal marijuana policy in the last year of the Obama administration are likely to be disappointed.
Marijuana advocates hoping for a substantial shift in federal marijuana policy in the last year of the Obama administration are likely to be disappointed.
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.